ZA201001997B - Method for controlling diseases of jatropha - Google Patents

Description

+ Eevee

DESCRIPTION Technical Field

The present invention relates to a method for controlling diseases of Jatropha.

Background Art

Jatropha is a deciduous shrub from the family

Euphorbiaceae. Species of Jatropha include Jatropha curcus, and oil contained in its seed is used as a raw material of bio-diesel fuel (BDF).

Nowadays, a lot of plant disease controlling agents are commercially available and used [see, for example, The

Pesticide Manual, Fourteenth Edition (2006), British Crop

Protection Council (ISBN: 1-901396-14-2)]. However, it is not known what kind of chemicals should be used for effectively controlling diseases occurring on Jatropha.

Disclosure of the Invention

An object of the present invention is to provide a method for effectively controlling diseases occurring on :

Jatropha.

The present invention provides a method for controlling a disease of Jatropha, which comprises applying a) 01070194 7 an effective amount of at least one compound selected from a compound group as listed below to Jatropha or a place where Jatropha is cultivated, and the compound group consists of: (1) azole compounds: propiconazole, prothioconazole, triadimenol, prochloraz, penconazole, tebuccnazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, flutriafol, simeconazole, ipconazole, and oxpoconazole fumarate; (2) amine compounds: fenpropimorph, tridemorph, fenpropidin, and spiroxamine; (3) benzimidazole compounds: carbendazim, benomyl, : thiabendazole, and thiophanate-methyl; (4) dicarboxyimide compounds: procymidone, iprodione, and vinclozolin; : (5) anilinopyrimidine compounds: cyprodinil, pyrimethanil, and mepanipyrim; (6) phenylpyrrole compounds: fenpiclonil, and fludioxonil; (7) strobilurin compounds: kresoxim-methyl, azoxystrobin, i trifloxystrobin, fluoxastrobin, picoxystrobin, pyraclostrobin, dimoxystrobin, pyribencarb, metominostrobin, oryzastrobin, enestrobin, and an «-alkoxyphenylacetic acid

Pole, compound represented by the formula (1): 0 x7 ot (1)

X 0% :

O I wherein X® represents methyl, difluoromethyl or ethyl, X represents methoxy or methylamino, and X° represents phenyl, 2-methylphenyl or 2,5-dimethylphenyl; (8) phenylamide compounds: metalaxyl, metalaxyl-M or mefenoxam, benalaxyl, and benalaxyl-M; (9) carboxylic acid amide compounds: dimethomorph, iprovalicarb, benthivalicarb-isopropyl, mandipropamid, and valiphenal; (10) carboxamide compounds: carboxin, mepronil, flutolanil, thifluzamide, boscalid, and fluopyram; and . (11) other compounds: diethofencarb, thiuram, fluazinan, mancozeb, chlorothalonil, captan, dichlofluanid, folpet, quinoxyfen, fenhexamid, famoxadone, fenamidone, zoxamide, ethaboxam, amisulbrom, cyazofamid, metrafenone, cyflufenamid, proquinazid, flusulfamide, fluopicolide, : fosetyl, cymoxanil, pencycuron, tolclofos-methyl, carpropamid, diclocymet, fenoxanil, tricyclazole, pyroguilon, probenazole, isotianil, tiadinil, tebufloqguin, diclomezine, kasugamycin, ferimzone, fthalide, validamnycin, hydroxyisoxazole, iminoctadine albesilate, iminoctadin

[a5 9D iz, il) “2010/7019, , 4 acetate, isoprothiolane, oxolinic acid, oxytetracycline, streptomycin, basic copper chloride, cupric hydroxide, basic copper sulfate, oxyquinoline copper, sulfur, a polyoxin complex, polycarbamate, fluopyram, a pyrazole 5 carboxamide compound represented by the formula (2): 0) Q

X 4 ? H

Ny X, 2

CH, wherein Xx! represents hydrogen or halogen, x? represents methyl, difluoromethyl or trifluoromethyl, and Q represents any one of the following groups: a cl cl (Q1) ] Q2) Q3 g =~

Seale

F

AIL ha / , and a pyrazolinone compound represented by the formula (3):

I

QO

NX x8 I (3)

N\ Nr h NH, O wherein X° represents methoxy, ethoxy, propoxy, 2- propenyloxy, 2-propynyloxy, 3-butenyloxy, 3-butynyloxy, :

=2010/0 19 7 methylthio, ethylthio or 2-propenylthio, X' represents 1- methylethyl or l-methylpropyl, and X® represents 2- methylphenyl or 2,6-dichlorophenyl.

According to the present invention, it is possible to 5 provide a method for effectively controlling diseases occurring on Jatropha.

Mode for Carrying Out the Invention

The method of the present invention is a method for controlling a disease occurring on Jatropha by applying an effective amount of (a) specific compound(s) to Jatropha or a place where Jatropha is cultivated.

The specific compound(s) is at least one compound selected from the compound group consisting of compounds (1) to (11) as listed above (hereinafter, sometimes, collectively referred to as "the present compound(s)").

In the present compound(s), examples of the o- alkoxyphenylacetic acid compound represented by the formula (1) include: a compound of the formula (1) wherein x’ is methyl, Xx? is methoxy and X° is 2,5-dimethylphenyl; a compound of the formula (1) wherein x3 is methyl, Xx? is methylamino and X° is phenyl; and ) a compound of the formula (1) wherein x3 is methyl, x! is methylamino and X° is 2,5-dimethylphenyl.

Cl

20 10/0199 7

Examples of the pyrazole carboxamide compound represented by the formula (2) include: a compound of the formula (2) wherein X' is chlorine, xX? is methyl and Q is Ql (general name: furametpyr): a compound of the formula (2) wherein x! is hydrogen, X° is trifluoromethyl and Q is Q2 (general name: penthiopyrad); a compound of the formula (2) wherein xt is hydrogen, x? is difluoromethyl and Q is Q3 (general name: bixafen), a compound of the formula (2) wherein X' is fluorine, x? is methyl and Q is Q4; a compound of the formula (2) wherein x! is hydrogen, xX? is difluoromethyl and Q is Q5; and a compound of the formula (2) wherein x! is hydrogen, xX? is difluoromethyl and Q is Q6.

Examples of the pyrazolinone compound represented by the formula (3) include: a compound of the formula (3) wherein X° is ethylthio, x’ is l-methylethyl and X% is 2,6-dichlorophenyl; and a compound of the formula (3) wherein x8 is 2-propenylthio, : xX" is l-methylethyl and X® is 2-methylphenyl.

Preferable examples of the present compound(s) include chlorothalonil, azoxystrobin, iprodione, iminoctadine albesilate, iminoctadine acetate, oxpoconazole fumarate, captan, kresoxim-methyl, diethofencarb, thiophanate-methyl, tebuconazole, fenhexamid, fluazinam, fludioxonil,

i di] ‘ “ =€010/019¢ 4 7 procymidone, benomyl, boscalid, a polyoxin complex, polycarbamate, mancozeb, mepanipyrim, oxyquinoline copper, an o-alkoxyphenylacetic acid compound represented by the formula (I):

CH,

Oo (1) § CH / oo” :

HC

C Oo

H, (hereinafter, sometimes, referred to as "the compound (I)"), a compound represented by the following formula (II): . CH, tH, O PY

N CH,

CH, (11)

HN fe] (hereinafter, sometimes, referred to as "the compound (IT)"), metconazole, prothioconazole, pyrimethanil, cyprodinil, pyribencarb, pyraclostrobin, dimoxystrobin, bixafen, fluopyram and penthiopyrad.

Examples of the diseases which can be controlled by the method of the present invention include diseases caused by the following pathogens:

Magnaporthe grisea, Cochliobolus miyabeanus, Rhizoctonia solani, Gibberella fujikuroi, Erysiphe graminis, Fusarium graminearum, F. avenacerum, F. culmorum, Microdochium

‘ nivale, Puccinia striiformis, P. graminis, P. recondita, P. hordei, Typhula sp., Micronectriella nivalis, Ustilago tritici, U. nuda, Tilletia caries, Pseudocercosporella herpotrichoides, Rhynchosporium secalis, Septoria tritici,

Leptosphaeria nodorum, Pyrenophora teres Drechsler,

Diaporthe citri, Elsinoce fawcetti, Penicillium digitatum, P. italicum, Phytophthora parasitica, Phytophthora citrophthora, Monilinia mali, Valsa ceratosperma,

Podosphaera leucotricha, Alternaria alternata apple pathotype, Venturia inaequalis, Colletotrichum acutatum,

Phytophtora cactorum, Venturia nashicola, V. pirina, )

Alternaria alternata Japanese pear pathotype,

Gymnosporangium haraeanum, Phytophtora cactorum, Monilinia fructicola, Cladosporium carpophilum, Phomopsis sp.,

Elsinoe ampelina, Glomerella cingulata, Uncinula necator,

Phakopsora ampelopsidis, Guignardia bidwellii, Plasmopara viticola, Gloeosporium kaki, Cercospora kaki,

Mycosphaerella nawae, Colletotrichum lagenarium,

Sphaerotheca fuliginea, Mycosphaerella melonis, Fusarium oxysporum, Pseudoperonospora cubensis, Phytophthora sp., ) Pythium sp., Alternaria solani, Cladosporium fulvum,

Phytophthora infestans, Phomopsis vexans, Erysiphe cichoracearum, Alternaria japonica, Cercosporella brassicae,

Plasmodiophora brassicae, Peronospora parasitica, Puccinia allii, Peronospora destructor, Cercospora kikuchii, Elsinoe !

‘ 21201070199 3 glycines, Diaporthe phaseolorum var. sojae, Phakopsora pachyrhizi, Phytophthora sojae, Colletotrichum lindemthianum, Cercospora personata, Cercospora arachidicola, Sclerotium rolfsii, Erysiphe pisi, Alternaria solani, Phytophthora infestans, Phytophthora erythroseptica,

Spongospora subterranean f. sp. subterranea, Sphaerotheca humuli, Glomerella cingulata, Exobasidium reticulatum,

Elsinoe leucospila, Pestalotiopsis sp., Colletotrichum theae-sinensis, Alternaria longipes, Erysiphe cichoracearum,

Colletotrichum tabacum, Peronospora tabacina, Phytophthora nicotianae, Cercospora beticola, Thanatephorus cucumeris,

Thanatephorus cucumeris, Aphanomyces cochlioides,

Diplocarpon rosae, Sphaerotheca pannosa, Peronospora sparsa,

Bremia lactucae, Septoria chrysanthemi-indici, Puccinia horiana, Pythium aphanidermatum, Pythium debarianum,

Pythium graminicola, Pythium irregulare, Pythium ultimum, ] Botrytis cinerea, Sclerotinia sclerotiorum, Alternaria brassicicola, Sclerotinia homeocarpa, Rhizoctonia solani,

Mycosphaerella fijiensis, Mycosphaerella musicola,

Plasmopara halstedii, Aspergillus spp., Penicillium spp.,

Fusarium spp., Gibberella spp., Irichoderma spp.,

Thielaviopsis spp., Rhizopus spp., Mucor spp., Corticium spp., Phoma spp., Rhizoctonia spp., and Diplodia spp.; and viral diseases mediated by Polymyxa spp., Olpidium spp., and so on.

10 a

In the method of the present invention, Jatropha to which the present compound(s) is applied may be a grown plant or a seed of Jatropha. In the method of the present invention, the place where Jatropha is cultivated to which the present compound(s) 1s applied is usually a Jatropha farm, and may be a place where Jatropha has been already cultivated or a place where Jatropha will be cultivated (i.e., before initiation of cultivation).

Jatropha used herein also includes Jatropha to which tolerance to HPPD inhibitors such as isoxaflutole, ALS inhibitors such as imazethapyr and thifensulfuron methyl,

EPSP synthase inhibitors such as glyphosate, glutamine synthase inhibitors such as glufosinate, acetyl CoA . carboxylase inhibitors such as sethoxydim, PPO inhibitors such as £iwmionnain, or herbicides such as bromoxynil, dicamba and 2,4-D has been conferred by a classical breeding method or a genetic engineering technique.

Jatropha used herein also includes Jatropha to which an ability of synthesizing a selective toxin known in genus

Bacillus has been conferred by using genetic engineering } techniques.

Examples of the toxin expressed in such genetically- engineered Jatropha include insecticidal proteins derived from Bacillus cereus and Bacillus popillige; d-endotoxins derived from Bacillus thuringiensis such as CrylAb, CrylAc,

CrylF, CrylFa2, Cry2Ab, Cry3A, Cry3Bbl and Cry9C, and insecticidal proteins such as VIP1l, VIP2, VIP3 and VIP3A; insecticidal proteins derived from nematodes; toxins produced by animals such as scorpion toxins, spider toxins, ;

S bee toxins, and insect-specific neurotoxins; fungal toxins; plant lectin; agglutinin; protease inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, and papain inhibitors; ribosome inactivating proteins (RIP) such as ricin, corn-RIP, abrin, luffin, saporin, and briodin; steroid metabolizing enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP- glucosyltransferases, and cholesterol oxidase; ecdysone inhibitors; HMG-CoA reductases; ion channel inhibitors such as sodium channel inhibitors and calcium channel inhibitors; juvenile hormone esterase; diuretic hormone receptors; antidiuretic hormone receptors; stilbene synthase; bibenzyl synthase; chitinase; and glucanase.

The toxin expressed in such genetically-engineered

Jatropha also includes hybrid toxins, partial deficient toxins and modified toxins of O-endotoxin proteins such as

CrylaAb, CrylAc, CrylF, CrylFa2, Cry2Ab, Cry3A, Cry3Bbl and

Cry9C, and insecticidal proteins such as VIPl, VIP2, VIP3, and VIP3A. The hybrid toxins can be produced by a new combination of different domains of these proteins using a genetic engineering technique. As the partial deficient toxins, for example, CrylAb whose amino acid sequence has been partially deleted is known. The modified toxins can be produced by substitution of one or a plurality of amino : acids of natural toxins.

These toxins are described in, for example, EP-A- 0374753, W093/07278, WO95/34656, EP-A-0427 529, EP-A-451878, and WO03/052073.

These toxins confer resistance particularly against coleopterous insect pests, dipterous insect pests or lepidopteraous insect pests to Jatropha.

Jatropha used herein also includes Jatropha to which an ability of producing an antipathogenic substance having a selective action has been conferred by using genetic engineering techniques.

Examples of the antipathogenic substance include PR proteins (PRPs; described in EP-A-0392225); ion channel inhibitors such as sodium channel inhibitors and calcium channel inhibitors (e.g., KPl, KP4 and KP6 toxins produced by virus are known); stilbene synthase; bibenzyl synthase; chitinase; glucanase; substances produced by microorganisms such as antibiotic peptides, antibiotics having hetero rings, and protein factors involved in plant disease resistance. These antipathogenic substances are described in, for example, EP-A-0392225, W095/33818 and EP-A-0353191.

Jatropha used herein also includes Jatropha to which useful traits such as those for modifying oily ingredients and reinforcing amino acid content have been conferred by using genetic engineering techniques.

Furthermore, Jatropha used herein also includes stacked varieties which have in combination a plurality of the above classical herbicide tolerant traits, useful traits which have been conferred by herbicide tolerance genes, insecticidal protein genes or antipathogenic substances-producing genes, or traits for modifying oily ingredients or reinforcing amino acid content.

The present compound(s) is usually formulated into a form suited for an intended purpose before use by dissolving or dispersing in a suitable liquid carrier, mixing with a suitable solid carrier, or adsorbing on a suitable solid carrier. Such formulation of the present invention takes the form of, for example, an emulsifiable concentrate, a liguid formulation, an oil solution, an aerosol, a wettable powder, a dust, a DL (driftless) dust, a granule, a microgranule, a microgranule F, a fine granule

F, a water dispersible granule, a water-soluble formulation, a suspension concentrate, a dry flowable formulation, a packed granule, a tablet, or a paste. If necessary, these formulations can further contain formulation adjuvants such as an emulsifier, a dispersant, a spreading agent, a penetrant, a moistening agent, a binder, a thickener, a

Rony preservative, an antioxidant, and a colorant, and can be prepared by a known method.

Examples of the liquid carrier used for the formulation include water, alcohols (e.g., methanol, ethanol, l-propanol, 2-propanol, ethylene glycol, etc.), ketones (e.g., acetone, methyl ethyl ketone, etc.), ethers (e.g., dioxane, tetrahydrofuran, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, etc.), aliphatic hydrocarbons (e.g., hexane, octane, cyclohexane, kerosene, fuel oil, machine oil, etc.), aromatic hydrocarbons (e.g., benzene, toluene, xylene, solvent naphtha, methylnaphthalene, etc.), halogenated hydrocarbons -(e.g., dichloromethane, chloroform, carbon tetrachloride, etc.), acid amides (e.qg., dimethylformamide, dimethylacetamide, N-methyl pyrrolidone, etc.), esters (e.g., ethyl acetate, butyl acetate, fatty acid glycerin ester, etc.), and nitriles (e.qg., acetonitrile, propionitrile, etc.). These liquid carriers can also be used by mixing two or more thereof in an appropriate ratio.

Examples of the solid carrier used for the formulation include vegetable powders (e.g., soybean powder, tobacco powder, wheat flour, wood powders, etc.), mineral powders (e.g., clays such as kaolin, bentonite, acidic white clay and clay, talcs such as talcum powder and pyrophyllite,

silicas such as diatomaceous earth and mica, etc.), alumina, a sulfur powder, activated carbon, saccharides (e.g., lactose, glucose, etc.), inorganic salts (e.g., calcium carbonate, sodium hydrogen carbonate, etc.), and glass hollow materials (prepared by subjecting natural glass to calcination processing to encapsulate bubbles therein).

These solid carriers can also be used by mixing two or more thereof in an appropriate ratio.

The liquid carrier or solid carrier is usually used in a ratio of about 1 to 99% by weight, and preferably about 10 to 99% by weight, based on the entire formulation.

Usually, a surfactant is used as the emulsifier, dispersant, spreading agent, penetrant or moistening agent to be used for the formulation. Examples of the surfactant include anionic surfactants such as alkyl sulfate ester salts, alkylaryl sulfonate, dialkyl sulfosuccinate, polyoxyethylene alkylaryl ether phosphate, lignin sulfonate and naphthalene sulfonate-formaldehyde polycondensate; and non-ionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkylaryl ether, polyoxyethylene alkyl polyoxypropylene block copolymers and sorbitan fatty acid ester. These surfactants can be used alone or in combination of two or more kinds thereof. The surfactant is usually used in a ratio of 0.1 to 50% by weight, preferably from about 0.1 to 25% by weight, based on the entire formulation.

Examples of the binder and the thickener include dextrin, sodium salt of carboxymethyl cellulose, polycarboxylate polymer compounds, polyvinyl pyrrolidone, polyvinyl alcohol, sodium lignin sulfonate, calcium lignin sulfonate, sodium polyacrylate, gum arabic, sodium alginate, mannitol, sorbitol, bentonite mineral, polyacrylic acid and derivatives thereof, white carbon, and natural saccharide derivatives (e.g., xanthan gum, guar gum, etc.).

When two or more present compounds are used in the method of the present invention, these compounds may be contained in the same formulation or separate formulations.

In the case of separate formulations each containing a different present compound, these formulations may be applied as a mixture or may be applied separately.

The amount of the present compound contained in the formulation as the active ingredient (in the case of using two or more present compounds, the total amount of the compounds) is usually from 1 to 90% by weight of the entire formulation in the case of an emulsifiable concentrate, a wettable powder, a water dispersible granule, a liquid formulation, a water soluble formulation, or a suspension concentrate; from 0.01 to 10% by weight of the entire formulation in the case of an oil solution, a dust, or a DL dust; and from 0.05 to 10% by weight of the entire formulation in the case of a microgranule, a microgranule F, a fine granule F, or a granule. However, these concentrations can be appropriately changed depending on the particular intended purpose. Usually, such a formulation as an emulsifiable concentrate, a wettable powder, a water dispersible granule, a liquid formulation, a water-soluble formulation or a suspension concentrate is appropriately diluted with water or the like before use by about 100 to 100,000 times.

In the method of the present invention, the present compound (s) can be also used in admixture with or in combination with active ingredients of insecticides, acaricides, nematocides, safeners, fertilizers or soil conditioners as other active ingredients.

Examples of the active ingredients of insecticides include the following compounds (1) to (12): (1) organophosphorous compounds acephate, Aluminium phosphide, butathiofos, cadusafos, chlorethoxyfos, chlorfenvinphos, chlorpyrifos, chlorpyrifos-methyl, cyanophos:CYRAP, diazinon,

DCIP(dichlorodiisopropyl ether), dichlofenthion: ECP, dichlorvos:DDVP, dimethoate, dimethylvinphos, disulfoton,

EPN, ethion, ethoprophos, etrimfos, fenthion: MPP, fenitrothion: MEP, fosthiazate, formothion, Hydrogen phosphide, isofenphos, isoxathion, malathion, mesulfenfos,

methidathion: DMTP, monocrotophos, naled:BRP, oxydeprofos:

ESP, parathion, phosalone, phosmet:PMP, pirimiphos-methyl, pyridafenthion, quinalphos, phenthoate: PAP, profenofos, propaphos, prothiofos, pyraclorfos, salithion, sulprofos, tebupirimfos, temephos, fetrachlevvinphes, terbufos, thiometon, trichlorphon:DEP, vamidothion, phorate, cadusafos, etc.; (2) carbamate compounds alanycarb, bendiocarb, benfuracarb, BPMC, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, . fenobucarb, fenothiocarb, fenoxycarb, furathiocarb, : isoprocarb: MIPC, metolcarb, methomyl, methiocarb, NAC, oxamyl, pirimicarb, propoxur:PHC, XMC, thiodicarb, xylylcarb, aldicarb, etc.:; (3) synthetic pyrethroid compounds acrinathrin, allethrin, benfluthrin, beta-cyfluthrin, bifenthrin, cycloprothrin, cyfluthrin, .cyhalothrin, cypermethrin, deltamethrin, esfenvalerate, ethofenprox, fenpropathrin, fenvalerate, flucythrinate, flufenoprox, flumethrin, fluvalinate, halfenprox, imiprothrin, permethrin, prallethrin, pyrethrins, resmethrin, sigma- i cypermethrin, silafluofen, tefluthrin, tralomethrin, transfluthrin, tetramethrin, phenothrin, cyphenothrin, alpha-cypermethrin, zeta-cypermethrin, lambda-cyhalothrin, furamethrin, tau-fluvalinate, 2,3,5,6-tetrafluoro-4-

13 . i (methoxymethyl)benzyl (EZ)-(1RS,3RS;1RS,3SR)-2,2-dimethyl- 3-prop-l-enylcyclopropanecarboxylate, 2,3,5,6-tetrafluoro- 4-methylbenzyl (EZ)-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-prop- l-enylcyclopropanecarboxylate, 2,3,5,6-tetrafluoro-4-

(methoxymethyl)benzyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2- methyl-l-propenyl)cyclopropanecarboxylate, etc.; {4) nereistoxin compounds cartap, bensultap, thiocyclam, monosultap and bisultap,

etc.;

(5) neonicotinoid compounds imidacloprid, nitenpyram, acetamiprid, thiamethoxam, thiacloprid, dinotefuran, clothianidin, etc.; (6) benzoylurea compounds chlorfluazuron, bistrifluron, diafenthiuron,

diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, triazuron, etc.;

(7) phenylpyrazole compounds acetoprole, ethiprole, fipronil, vaniliprole, : 20 pyriprole, pyrafluprole, etc.; (8) Bt toxin live spores or crystal toxins derived from Bacillus thuringiesis and a mixture thereof; (9) hydrazine compounds chromafenozide, halofenozide, methoxyfenozide,

! tebufenoczide, etc.; (10) organic chlorine compounds aldrin, dieldrin, dienochlor, endosulfan, methoxychlor, etc.; (11) natural insecticidal compounds : machine oil, nicotine-sulfate, etc.; and (12) other insecticidal compounds . avermectin-B, bromopropylate, buprofezin, chlorphenapyr, cyromazine, D-D (1,3-Dichloropropene), emamectin-benzoate, fenazaquin, flupyrazofos, hydroprene, methoprene, indoxacarb, metoxadiazone, milbemycin-A, pymetrozine, pyridalyl, pyriproxyfen, spinosad, sulfluramid, tolfenpyrad, triazamate, flubendiamide, lepimectin, Arsenic acid, benclothiaz, Calcium cyanamide, Calcium polysulfide, chlordane, DDT, DSP, flufenerim, flonicamid, flurimfen, formetanate, metam-ammonium, metam-sodium, Methyl bromide, nidinotefuran, Potassium oleate, protrifenbute, spiromesifen, Sulfur, metaflumizone, spirotetramat, pyrifluquinazone, spinetoram, chlorantraniliprole, a compound represented by the following formula (4):

R, o J

R, vA

NC o N/

RR, R- ; wherein

R; represents methyl, Cl, Br or F,

R; represents F, Cl, Br, Cl1-C4 haloalkyl, or Cl-C4 haloalkoxy,

Rs represents F, Cl or Br,

R; represents H; or

Cl-C4 alkyl, C3-C4 alkenyl, C3-C4 alkynyl, C3-C5 cycloalkyl or C4-C6 cycloalkylalkyl which is optionally substituted with one or more members selected from the group consisting of halogen, cyano, thiomethyl, S(O)Me, S(0),Me and OMe,

Rs represents H or methyl,

R¢ represents H, F or Cl, and

Ry; represents H, F or Cl; and a compound represented by the following formula (5): i § Con oy ° o N_ “3 (5) wherein X represents Cl, Br or I.

Examples of the active ingredients of acaricides include: aceqguinocyl, amitraz, benzoximate, bifenaate, bromopropylate, chinomethionat, chlorobenzilate,

CPCBS (chlorfenson), clofentezine, cyflumetofen, kelthane (dicofol), etoxazole, fenbutatin oxide,

fenothiocarb, fenpyroximate, fluacrypyrim, fluproxyfen, hexythiazox, propargite: BPPS, polynactins, pyridaben,

Pyrimidifen, tebufenpyrad, tetradifon, spirodiclofen, spiromesifen, spirotetramat, amidoflumet, and cyenopyrafen.

Examples of the active ingredients of nematocides include DCIP, fosthiazate, levamisol, methyisothiocyanate, morantel tartarate, and imicyafos.

Examples of the active ingredients of safeners include: 1,8-naphthalic anhydride, cyometrinil, oxabetrinil, fluxofenim, flurazole, benoxacor, dichlormid, furilazole, fenclorim, daimuron, cumyluron, dimepiperate, cloquintocet- mexyl, fenchlorazole~ethyl, mefenpyr-diethyl, and isoxadifen-ethyl.

When the present compound(s) is used in combination with the other active ingredients as listed above in the method of the present invention, the weight ratio of the present compound(s) to the other active ingredients is usually within a range from 1 : 0.005 to 1 : 100, preferably from 1 : 0.01 to 1 : 50.

The present compound(s) and the other active ingredients may be contained in the same formulation or separate formulations.

In the method of the present invention, the application of the present compound(s) can be attained by the same method as a conventional method for application of a known pesticide, examples of which include aerial application, soil application, foliage application, and seed application. In the method of the present invention, specifically, foliage application, such as treatment of the stems and leaves of Jatropha; soil treatment, such as a treatment of a place where Jatropha is cultivated; or seed sterilization or seed coating, such as treatment of a seed of Jatropha is performed.

Specific examples of the foliage application performed in the method of the present invention include methods comprising applying the present compound(s) to the surface of a plant, such as foliage spraying or trunk spraying.

Examples of the soil treatment performed in the method of the present invention include soil broadcast, scil incorporation, and soil drenching of a chemical solution (e.g. irrigation of a chemical solution, soil injection, or dripping of a chemical solution). Examples of a place to be treated include a planting hole, a row, a periphery of a planting hole, a periphery of a row, the entire surface of a cultivation area, soil at the base of a plant, a space between plants, soil around trunk, a main trunk ridge, culture soil, a seedling raising box, a seedling raising tray, and a nursery bed. Examples of the treatment timing include before sowing, at the time of sowing, immediately

! after sowing, a seeding raising period, before fix planting, at the time of fix planting, and a growing period after fix planting. In the soil treatment, a plant may be simultaneously treated with the active ingredient, and also a solid fertilizer such as a paste fertilizer containing - the active ingredient may be applied to the soil. The active ingredient may be mixed with ah irrigation liquid, and examples of mixing with an irrigation liquid include an injection to irrigation facilities (e.g. irrigation tube, irrigation pipe, sprinkler, etc.), mixing with a flooding liquid between rows, and mixing with a water culture medium.

Alternatively, the active ingredient is mixed with a liquid for irrigation in advance, and then the liquid can be used for a soil treatment by the above-described irrigation method, or a proper irrigation method such as sprinkling or flooding.

Examples of the seed treatment performed in the method of the present invention include methods comprising applying the present compound(s) directly to seeds or to the periphery of seeds, and specific examples thereof include a spraying treatment in which a suspension of the present compound(s) is sprayed over the seed surface; a coating treatment in which seeds are coated with a wettable powder, an emulsifiable concentrate or a flowable formulation of the present compound(s), or a mixture of a wettable powder, an emulsifiable concentrate or a flowable formulation of the present compound(s) with a small amount of water; an immersion treatment in which seeds are immersed in a suspension cr an organic solvent solution of the present compound(s) for a certain time; a film coating treatment; and a pellet coating treatment.

The amount of the present compound(s) to be used varies depending on an application area, an application period, an application method or a disease to be controlled, and however, it is usually from about 1 to 20,000 g, preferably from about 10 to 5,000 g per 1 hectare of a place where Jatropha is cultivated.

EXAMPLES

The present invention will be described in more detail by way of Formulation Examples, Treatment Examples and Test

Examples to which the present invention is not limited.

Formulation Examples are shown below. Herein, the term "part (s)" means part(s) by weight.

Formulation Example 1

An emulsifiable concentrate is obtained by thoroughly mixing 30 parts of the compound (I), 14 parts of polyoxyethylene styryl phenyl ether, © parts of calcium dodecylbenzenesulfonate and 76.25 parts of xylene.

Formulation Example 2

A mixture of 30 parts of the compound (II), 35 parts of a mixture of white carbon and a polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1 : 1), and 55 parts of water is finely ground by a wet grinding method to obtain a flowable formulation.

Formulation Example 3

A mixture of 10 parts of the compound (I), 1.5 parts of sorbitan trioleate, and 28.5 parts of an agueocus solution containing 2 parts of a polyvinyl alcohol is finely ground by a wet grinding method. To the finely ground mixture thus obtained are added 45 parts of a solution of 0.05 parts of xanthan gum and 0.1 parts of aluminum magnesium silicate in water, and then 10 parts of propylene glycol. The mixture is stirred to obtain a flowable formulation.

Formulation Example 4

A mixture of 20 parts of the compound (I), 1.5 parts of sorbitan trioleate, and 28.5 parts of a solution of 2 parts of polyvinyl alcohol in water is finely ground by a wet grinding method. To the finely ground mixture thus obtained are added 45 parts of a solution of 0.05 parts of xanthan gum and 0.1 parts of aluminum magnesium silicate in water, and then 10 parts of propylene glycol. The mixture is stirred to obtain a flowable formulations for seed treatment.

Formulation Example 5

A bulk slurry is prepared by mixing 40 parts of the compound (II), 5 parts of imidacleprid, 5 parts of propylene glycol (Nakarai Tesque, Inc.), 5 parts of

Soprophor FLK (trade name; Rhodia Nicca), 0.2 parts of

ANTIFOAM C EMULSION (trade name; Dow Corning Corporation), 0.3 parts of PROXEL GXL (trade name; Arch Chemical, Inc.) and 49.5 parts of ion-exchange water. Then, 150 parts of glass beads (® = 1 mm) is put into 100 parts of the slurry.

The mixture is ground for 2 hours while it is cooled with cooling water. After grinding, the glass beads are removed by filtration to obtain a flowable formulation for seed treatment. ‘

Formulation Example 6

An AT premix is obtained by mixing 50 parts of the compound (I), 38.5 parts of NN kaolin clay (TAKEHARA KAGAKU

KOGYO CO., LTD.), 10 parts of Morwet D425 (trade neme; Akzo

Nobel) and 1.5 parts of Morwer EFW (trade name; Akzo Nobel).

The premix is ground by using a jet mill to obtain a dust for dry seed treatment. i

Formulation Example 7

A mixture of 1 part of the compound (I), 4 parts of , clothianidin, 1 part of synthetic hydrated silicon oxide, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 57 parts of kaolin clay is thoroughly ground. The ground mixture is thoroughly kneaded with water, granulated and then dried to obtain a granule.

Formulation Example 8

A mixture of 10 parts of the compound (I), 10 parts of the compound (II), 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate and 54 parts of synthetic hydrated silicon oxide is thoroughly ground to obtain a wettable powder.

Formulation Example 9

A mixture of 1 part of the compound (I), 4 parts of thiamethoxam, 1 part of synthetic hydrated silicon oxide, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 57 parts of kaolin clay is thoroughly ground. The ground mixture is thoroughly kneaded with water, granulated and then dried to obtain a granule.

Hereinafter, Seed Treatment Examples are shown below.

Seed Treatment Example 1

Jatropha dry seeds (100 kg) are coated with the emulsifiable concentrate (500 ml) obtained in accordance with Formulation Example 1 by using a rotary seed treating machine (Seed Dressor; Hans-Ulrich Hege GmbH) to obtain treated seeds.

Seed Treatment Example 2

Jatropha dry seeds (10 kg) are coated with the flowable formulation (50 ml) obtained in accordance with

Formulation Example 2 by using a rotary seed treating machine (Seed Dressor; Hans-Ulrich Hege GmbH) to obtain treated seeds.

Seed Treatment Example 3

Jatropha dry seeds (10 kg) are coated with the . flowable formulation (40 ml) obtained in accordance with

Formulation Example 3 by using a rotary seed treating machine (Seed Dressor; Hans-Ulrich Hege GmbH) to obtain treated seeds.

Test Examples are shown below.

Test Example 1

Field soil was put in a pot measuring 24 cm in

I

Claims (1)

“JUNI cL CLAIMS

1. A method for controlling a disease of Jatropha, which comprises applying an effective amount of at least one compound selected from a compound group as listed below ! to Jatropha or a place where Jatropha is cultivated, wherein the compound group consists of: (1) azole compounds: propiconazole, prothioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, flutriafol, simeconazole, ipconazole, and oxpoconazole fumarate; (2) amine compounds: fenpropimorph, tridemorph, fenpropidin, and spiroxamine; (3) benzimidazole compounds: carbendazim, benomyl, thiabendazole, and thiophanate-methyl; (4) dicarboxyimide compounds: procymidone, iprodione, and vinclozolin; (5) anilinopyrimidine compounds: cyprodinil, pyrimethanil, and mepanipyrim; (6) phenylpyrrole compounds: fenpiclonil, and fludioxonil; (7) strobilurin compounds: kresoxim-methyl, azoxystrobin,

trifloxystrobin, fluoxastrobin, picoxystrobin, pyraclostrobin, dimoxystrobin, pyribencarb, metominostrobin, oryzastrobin, enestrobin, and an o-alkoxyphenylacetic acid compound represented by the formula (1): h 0 x ot (1) X; oS i wherein x3 represents methyl, difluoromethyl or ethyl, x! represents methoxy or methylamino, and x° represents phenyl, 2-methylphenyl or 2,5-dimethylphenyl; (8) phenylamide compounds: metalaxyl, metalaxyl-M or mefenoxam, benalaxyl, and benalaxyl-M; (9) carboxylic acid amide compounds: dimethomorph, iprovalicarb, benthivalicarb-isopropyl, mandipropamid, and valiphenal; } (10) carboxamide compounds: carboxin, mepronil, flutolanil,

thifluzamide, boscalid, and fluopyram; and (11) other compounds: diethofencarb, thiuram, fluazinam, mancozeb, chlorothalonil, captan, dichlofluanid, folpet, quinoxyfen, fenhexamid, famoxadone, fenamidone, zoxamide, ethaboxam, amisulbrom, cyazofamid, metrafenone,

cyflufenamid, proquinazid, flusulfamide, fluopicolide, fosetyl, cymoxanil, pencycuron, tolclofos-methyl, carpropamid, diclocymet, fenoxanil, tricyclazole,

i pyrogquilon, probenazole, isotianil, tiadinil, tebufloquin, diclomezine, kasugamycin, ferimzone, fthalide, validamycin, hydroxyisoxazole, iminoctadine albesilate, iminoctadin acetate, isoprothiolane, oxolinic acid, oxytetracycline, streptomycin, basic copper chloride, cupric hydroxide, basic copper sulfate, oxyquinoline copper, sulfur, a polyoxin complex, polycarbamate, fluopyram, a pyrazole carboxamide compound represented by the formula (2): O Q edi

H . xX, @ & wherein X! represents hydrogen or halogen, x? represents methyl, difluoromethyl or trifluoromethyl, and Q represents any one of the following groups: Q cl al (Qn © ©3) C as t EAA ¢ / ' and a pyrazolinone compound represented by the formula (3):

{

0 X7 x8 I (3) N\ Nr NH, © wherein X°® represents methoxy, ethoxy, propoxy, 2- propenyloxy, 2-propynyloxy, 3-butenyloxy, 3-butynyloxy, methylthio, ethylthio or 2-propenylthio, xX! represents 1- methylethyl or l-methylpropyl, and X® represents 2- methylphenyl or 2, 6-dichlorophenyl.

DATED THIS 19 DAY OF MARCH 2010 SPOOR & FISHER APPLICANTS PATENT ATTORNEYS